Global Biomarker technologies Market Size study, by Product (Consumables, Service), by Type (Safety, Efficacy, Validation), by Disease Indication (Cancer, Cardiovascular Disorders), by Application (Diagnostics Development, Drug Discovery and Development, Disease-Risk) and by Regional Forecasts 2017-2025.

June 2018 | 120 pages | ID: GD7CC0481CDEN
Bizwit Research & Consulting LLP

Abstracts

Global Biomarker technologies Market to reach USD 96.8 billion by 2025.

Global Biomarker technologies Market valued approximately USD 42.8 billion in 2016 is anticipated to grow with a healthy growth rate of more than 9.7% over the forecast period 2017-2025. Key factors which give growth to the Biomarker technologies market are increasing diagnostic applications of biomarkers, increasing R&D funding for pharma and biotech companies, increasing number of CROs and low cost of clinical trials in developing countries, the high prevalence of cancer, and new initiatives for biomarker research. On the other hand, high capital investments and low cost-benefit ratio, poorly suited regulatory and reimbursement systems, and technical issues related to sample collection and storage are the major factors restraining the growth of this market.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

• Consumables
• Service

By Type:

• Safety
• Efficacy
• Validation

By Disease indication:

• Cancer
• Cardiovascular disorders

By Application:

• Diagnostics development
• Drug discovery and development
• Disease risk

By Regions:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• Asia Pacific
• China
• India
• Japan
• Latin America
• Brazil
• Mexico
• Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2015
Base year – 2016
Forecast period – 2017 to 2025

Some of the key manufacturers involved in the market Qiagen N.V., Perkinelmer Inc., Merck Millipore, Bio-Rad laboratories Inc., Enzo Biochem Inc., Biosims technologies sas, Cisbio bioassays. Acquisitions and effective mergers are some of the strategies adopted by the key manufacturers. New product launches and continuous technological innovations are the key strategies adopted by the major players.

Target Audience of the Global Biomarker technologies Market in Market Study:

• Key Consulting Companies & Advisors
• Large, medium-sized, and small enterprises
• Venture capitalists
• Value-Added Resellers (VARs)
• Third-party knowledge providers
• Investment bankers
• Investors

Contents

CHAPTER 1. GLOBAL BIOMARKER TECHNOLOGIES MARKET DEFINITION AND SCOPE

1.1. Research Objective
1.2. Market Definition
1.3. Scope of The Study
1.4. Years Considered for The Study
1.5. Currency Conversion Rates
1.6. Report Limitation

CHAPTER 2. RESEARCH METHODOLOGY

2.1. Research Process
  2.1.1. Data Mining
  2.1.2. Analysis
  2.1.3. Market Estimation
  2.1.4. Validation
  2.1.5. Publishing
2.2. Research Assumption

CHAPTER 3. EXECUTIVE SUMMARY

3.1. Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion)
3.2. Key Trends

CHAPTER 4. GLOBAL BIOMARKER TECHNOLOGIES MARKET DYNAMICS

4.1. Growth Prospects
  4.1.1. Drivers
  4.1.2. Restraints
  4.1.3. Opportunities
4.2. Industry Analysis
  4.2.1. Porter’s 5 Force Model
  4.2.2. PEST Analysis
  4.2.3. Value Chain Analysis
4.3. Analyst Recommendation & Conclusion

CHAPTER 5. GLOBAL BIOMARKER TECHNOLOGIES MARKET, BY PRODUCT

5.1. Market Snapshot
5.2. Market Performance - Potential Model
5.3. Global Biomarker technologies Market, Sub Segment Analysis
  5.3.1. Consumables
    5.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    5.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  5.3.2. Services
    5.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    5.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

CHAPTER 6. GLOBAL BIOMARKER TECHNOLOGIES MARKET, BY TYPE

6.1. Market Snapshot
6.2. Market Performance - Potential Model
6.3. Global Biomarker technologies Market, Sub Segment Analysis
  6.3.1. Safety
    6.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    6.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  6.3.2. Efficacy
    6.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    6.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  6.3.3. Validation
    6.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    6.3.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

CHAPTER 7. GLOBAL BIOMARKER TECHNOLOGIES MARKET, BY DISEASE INDICATION

7.1. Market Snapshot
7.2. Market Performance - Potential Model
7.3. Global Biomarker technologies Market, Sub Segment Analysis
  7.3.1. Cancer
    7.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    7.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  7.3.2. Cardiovascular disorders
    7.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    7.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

CHAPTER 8. GLOBAL BIOMARKER TECHNOLOGIES MARKET, BY APPLICATION

8.1. Market Snapshot
8.2. Market Performance - Potential Model
8.3. Global Biomarker technologies Market, Sub Segment Analysis
  8.3.1. Diagnostics development
    8.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  8.3.2. Drug discovery & development
    8.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  8.3.3. Disease Risk
    8.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.3.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

CHAPTER 9. GLOBAL BIOMARKER TECHNOLOGIES MARKET, BY REGIONAL ANALYSIS

9.1. Biomarker technologies Market, Regional Market Snapshot (2015-2025)
9.2. North America Biomarker technologies Market Snapshot
  9.2.1. U.S.
    9.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    9.2.1.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.2.1.3. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.2.1.4. Disease indication breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.2.1.5. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
  9.2.2. Canada
    9.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    9.2.2.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.2.2.3. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.2.2.4. Disease indication breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.2.2.5. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3. Europe Biomarker technologies Market Snapshot
  9.3.1. U.K.
    9.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    9.3.1.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.3.1.3. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.3.1.4. Disease indication breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.3.1.5. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
  9.3.2. Germany
    9.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    9.3.2.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.3.2.3. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.3.2.4. Disease indication breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.3.2.5. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
  9.3.3. France
    9.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    9.3.3.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.3.3.3. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.3.3.4. Disease indication breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.3.3.5. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
  9.3.4. Rest of Europe
    9.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    9.3.4.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.3.4.3. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.3.4.4. Disease indication breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.3.4.5. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4. Asia Biomarker technologies Market Snapshot
  9.4.1. China
    9.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    9.4.1.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.4.1.3. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.4.1.4. Disease indication breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.4.1.5. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
  9.4.2. India
    9.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    9.4.2.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.4.2.3. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.4.2.4. Disease indication breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.4.2.5. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
  9.4.3. Japan
    9.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    9.4.3.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.4.3.3. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.4.3.4. Disease indication breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.4.3.5. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
  9.4.4. Rest of Asia Pacific
    9.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    9.4.4.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.4.4.3. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.4.4.4. Disease indication breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.4.4.5. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.5. Latin America Biomarker technologies Market Snapshot
  9.5.1. Brazil
    9.5.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    9.5.1.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.5.1.3. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.5.1.4. Disease indication breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.5.1.5. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
  9.5.2. Mexico
    9.5.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    9.5.2.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.5.2.3. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.5.2.4. Disease indication breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.5.2.5. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.6. Rest of The World
  9.6.1. South America
    9.6.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    9.6.1.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.6.1.3. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.6.1.4. Disease indication breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.6.1.5. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
  9.6.2. Middle East and Africa
    9.6.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    9.6.2.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.6.2.3. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.6.2.4. Disease indication breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.6.2.5. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

CHAPTER 10. COMPETITIVE INTELLIGENCE

10.1. Company Market Share (Subject to Data Availability)
10.2. Top Market Strategies
10.3. Company Profiles
  10.3.1. Qiagen N.V.
    10.3.1.1. Overview
    10.3.1.2. Financial (Subject to Data Availability)
    10.3.1.3. Product Summary
    10.3.1.4. Recent Developments
  10.3.2. Perkinelmer Inc.
  10.3.3. Merck Millipore
  10.3.4. Bio-Rad laboratories Inc.
  10.3.5. Enzo Biochem Inc.
  10.3.6. Biosims technologies sas
  10.3.7. Cisbio bioassays